SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech - Quaterly Results

28 Apr 2026 Evaluate
A fair growth of 20.97% in the revenue at Rs. 5161.38 millions was reported in the March 2026 quarter as compared to Rs. 4266.53 millions during year-ago period.Profit after tax for the quarter ended March 2026 reported a huge growth of 69.11% to Rs. 547.30  millions from Rs. 323.64 millions.The company reported a good operating profit of 863.27 millions compared to 545.96 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5161.38 4266.53 20.97 17520.66 14316.28 22.38 17520.66 14316.28 22.38
Other Income 227.29 23.96 848.62 270.09 57.42 370.38 270.09 57.42 370.38
PBIDT 863.27 545.96 58.12 2353.44 1919.77 22.59 2353.44 1919.77 22.59
Interest 38.10 30.75 23.90 133.49 95.84 39.28 133.49 95.84 39.28
PBDT 825.17 515.21 60.16 2219.95 1823.93 21.71 2219.95 1823.93 21.71
Depreciation 89.71 76.63 17.07 309.33 276.90 11.71 309.33 276.90 11.71
PBT 735.46 438.58 67.69 1910.62 1547.03 23.50 1910.62 1547.03 23.50
TAX 188.16 114.94 63.70 482.24 399.61 20.68 482.24 399.61 20.68
Deferred Tax 53.08 -8.57 -719.37 33.19 -22.25 -249.17 33.19 -22.25 -249.17
PAT 547.30 323.64 69.11 1428.38 1147.42 24.49 1428.38 1147.42 24.49
Equity 110.77 110.73 0.04 110.77 110.73 0.04 110.77 110.73 0.04
PBIDTM(%) 16.73 12.80 30.71 13.43 13.41 0.17 13.43 13.41 0.17

Rossari Biotech Share Price

478.75 10.95 (2.34%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×